Rayaldee Capsule, Extended Release
Product Images NDC 70301-1001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rayaldee (NDC 70301-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Calcifediol Chemical Structure (Image 01)

Chemical structure of calcifediol, the active ingredient in Rayaldee, shown as a steroid molecule with hydroxyl groups and one molecule of water (hydrate form).*

FDA Label Image

Figure 1 (Image 02)

Line graph depicting percent change from baseline over 26 weeks of treatment comparing Rayaldee (calcifediol) with placebo. The x-axis shows weeks of treatment, and the y-axis shows percent change. The Rayaldee group shows a downward trend, while the placebo group trends slightly upward over time.*

FDA Label Image

Principal Display Panil (Image 03)

Label for Rayaldee (calcifediol) extended-release capsules, each containing 30 mcg calcifediol. The label states Rx only and includes storage instructions and manufacturer information for OPKO Pharmaceuticals LLC, located in Miami, FL. The package size is 30 capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.